-
1 Comment
From a valuation standpoint, the stock is 100.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.0.
Based on the above factors, PainReform Ltd gets an overall score of 1/5.
| Sector | Healthcare |
|---|---|
| CurrencyCode | USD |
| ISIN | IL0011651580 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Exchange | NASDAQ |
| PE Ratio | None |
|---|---|
| Target Price | 12 |
| Market Cap | 2M |
| Beta | 0.77 |
| Dividend Yield | None |
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for PRFX using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2026